Cover: Making Outcome-Based Payment a Reality in the NHS

Making Outcome-Based Payment a Reality in the NHS

Phase 2: Practical Considerations

Published in: Cancer Research UK website (November 2021)

Posted on Dec 1, 2021

by Amanda Cole, Patricia Cubi-Molla, Rachel Elliott, Alexandra Feast, Lucy Hocking, Paula Lorgelly, Katherine Payne, Niels Peek, Duncan Sim, Jon Sussex, et al.

The second phase of the research undertaken by the Office of Health Economics, RAND Europe, University College London and Manchester University was published in November 2021. It sought to understand the extent of existing NHS data capture on these key outcomes and whether these data are in a form suitable for a national-level outcome-based payment (OBP) scheme. The report found that the outlook on data availability for OBP is positive for clinical outcomes such as survival and disease progression, but that improvements are still needed to capture data on patients' ability to return to normal activities and their long-term side effects—and to optimise and link these datasets to enable financial decisions.

The research also explored wider practical considerations for implementing OBP schemes in the NHS and found that these mainly relate to agreeing the rebate process and achieving buy-in from clinical staff, Trusts executives, and national system stakeholders.

We will soon begin exploring possibilities for convening relevant stakeholders, to discuss how these challenges can be overcome and recommendations implemented to develop the evidence-base further to understand the viability of OBP schemes in the future.

A supplementary report is also available.

Research conducted by

This report is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.